1-3 of 3
Thomas S. Mack
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLT3-Kinase Inhibitors Quizartinib and Midostaurin Do Not Impair T-Cell Reactivity and Activation

Denise Wolleschak, MD, Thomas S. Mack, MSc, Florian Perner, Tina M Schnoeder, PhD, Marie-Christine Wagner, Stefanie Kliche, PhD, Burkhart Schraven, Satish Ranjan, Berend H. Isermann, MD, Daniel B. Lipka, MD, Thomas Fischer, MD, Florian H Heidel, MD
Journal: Blood
Blood (2012) 120 (21): 1045.
https://doi.org/10.1182/blood.V120.21.1045.1045
Published: 2012
Journal Articles

Location of FLT3 -ITDs within the beta1-Sheet of FLT3 Kinase Confers Resistance to Tyrosine Kinase Inhibitors (TKI) in Vitro .

Thomas S. Mack, MSc, Patricia Arreba-Tutusaus, MSc, Tina M Schnoeder, PhD, Florian H Heidel, MD, Thomas Fischer, MD
Journal: Blood
Blood (2012) 120 (21): 2440.
https://doi.org/10.1182/blood.V120.21.2440.2440
Published: 2012
Journal Articles

Different FLT3 -ITD Integration Sites Are Associated with Differential Sensitivity to Tyrosine Kinase Inhibitors (TKI) In Vitro.

Thomas S. Mack, Marie-Christine Blum, Thomas Kindler, Daniel B. Lipka, MD, Florian H. Heidel, MD, Thomas Fischer, MD
Journal: Blood
Blood (2010) 116 (21): 1709.
https://doi.org/10.1182/blood.V116.21.1709.1709
Published: 2010